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Mild traumatic brain injury (mTBI) can impact gait, with deficits linked to underlying neural 30 
disturbances in cognitive, motor and sensory systems. Gait is complex as it is comprised of 31 
multiple characteristics that are sensitive to underlying neural deficits. However, there is currently 32 
no clear framework to guide selection of gait characteristics in mTBI. This study developed a 33 
model of gait in chronic mTBI and replicated this in a separate group of controls, to provide a 34 
comprehensive and structured methodology on which to base gait assessment and analysis.  35 
Methods 36 
Fifty-two people with chronic mTBI and 59 controls completed a controlled laboratory gait 37 
assessment; walking for two minutes back and forth over a 13m distance while wearing five 38 
wirelessly synchronized inertial sensors. Thirteen gait characteristics derived from the inertial 39 
sensors were selected for entry into the principle component analysis based on previous 40 
literature, robustness and novelty. Principle component analysis was then used to derive domains 41 
(components) of gait.  42 
Results 43 
Four gait domains were derived for our chronic mTBI group (variability, rhythm, pace and turning) 44 
and this was replicated in a separate control cohort. Domains totaled 80.8% and 77.4% of 45 
variance in gait for chronic mTBI and controls, respectively. Gait characteristic loading was 46 
unambiguous for all features, with the exception of gait speed in controls that loaded on pace and 47 
rhythm domains.  48 
Conclusion 49 
This study contributes a four component model of gait in chronic mTBI and controls that can be 50 
used to comprehensively assess and analyze gait and underlying mechanisms involved in 51 
impairment, or examine the influence of interventions.  52 
 53 




1. Introduction 56 
Gait assessment is a simple marker for overall health, as it predicts quality of life, survival, 57 
cognitive decline and falls [1]. Gait becomes more difficult with age and neurological deficits, 58 
which cause transfer from automatic to cognitive (higher level) control to maintain performance, 59 
particularly with complex environments or tasks [2]. Gait is complex and multifactorial, and 60 
therefore cannot be captured by one characteristic, such as gait speed which is universally used 61 
to reflect gait due to its robust clinometric properties [3]. Gait is comprised of multiple 62 
characteristics including temporal, spatial and variability characteristics that can further 63 
discriminate pathological effects; therefore, measuring multiple gait characteristics is critical to 64 
examine specific features of disease or injury [2]. Despite this, most previous mild traumatic brain 65 
injury (mTBI) gait research has focused on singular gait characteristics (i.e. primarily gait speed) 66 
[4], likely due to the ease of measurement and to avoid multiple comparison statistical issues. 67 
Gait speed is an accumulation of many gait features and although it provides a measure of global 68 
performance and is sensitive to pathology and age [3], it is not specific and therefore may not 69 
reflect precise underlying deficits [5]. For example, gait speed is not discriminative or reflective of 70 
subtle and selective alterations in gait that occur due to injury or illness [6-8]. Selective 71 
identification of gait characteristics is vital for discrimination of pathology, identifying specific 72 
features of injury or disease progression and discerning the effect of pathology via detection of 73 
shared neural substrates for gait and other features (e.g. cognition, sensory function etc.) [2]. For 74 
example, different cognitive domains and brain regions have selective relationships to specific 75 
gait features (pace, variability, rhythm etc.) [2, 9], therefore examining multiple aspects of gait 76 
may help to uncover underpinning neural impairments due to mTBI. Additionally, those with 77 
chronic mTBI typically have persistent symptoms that do not relate to gait speed, but may relate 78 
to other discrete gait characteristics (i.e. turning performance) [10].  79 
There are inconsistent reports of how gait is impaired in people with chronic mTBI. These mixed 80 
results could be due to the variable gait testing conditions (e.g. straight, turning, obstacle crossing, 81 
etc.), and gait characterization techniques (e.g. gait mats, camera-based motion capture, etc.), 82 
as well as limited cohorts involved (e.g. differing samples, small sample sizes, etc.). For chronic 83 
mTBI populations more than one year post injury, there are reports of no change or decrease of 84 
gait speed during straight gait and complex gait (e.g. obstacle crossing, uneven surfaces, 85 
crowded spaces etc.) under single and dual-task conditions [4]. Additionally, previous reports of 86 
increased double support time with chronic mTBI [4] has not been reproduced across two cohorts 87 
where age and mTBI history were matched [11, 12]. Similar trends for other spatiotemporal gait 88 
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characteristics, such as stride length, stride width, and stride time can be found throughout the 89 
chronic mTBI gait literature [4]. Some of the variability of these observations could be mitigated 90 
by comprehensively assessing gait through examination of gait domains accounting for many 91 
aspects of gait performance (e.g. pace, variability, rhythm, turning etc.) opposed to individual gait 92 
characteristics. Conceptual models of gait provide a simplified framework for grouping and 93 
selection of gait characteristics, which allow even small cohort studies to examine gait 94 
comprehensively through informed analysis of independent features of gait while avoiding 95 
redundancy.    96 
A comprehensive range of gait characteristics is required to detect selective and specific neural 97 
substrate relationships [2]. However, an issue of measuring multiple gait characteristics is high 98 
covariance amongst the measures, suggesting redundancy of some characteristics and a need 99 
to identify key components for sensitivity and specificity of pathology. Therefore, conceptual gait 100 
models have been developed to eliminate redundancy by assisting with data reduction and 101 
interpretation, which group gait characteristics into domains [5, 7, 13-15]. Domains provide a 102 
useful structure to interpret underlying contributions of various pathological deficits to gait. Data 103 
reduction methods, such as exploratory factor analysis and principle component analysis (PCA), 104 
have previously been used to examine and explain other complex physiological processes (e.g. 105 
cardiovascular disease [16]), and have been used to derive statistically independent domains of 106 
gait in various cohorts. Development of a pathology specific gait model facilitates robust 107 
investigation into underlying mechanisms involved in gait impairment [8], which helps identify 108 
specific features that contribute to gait deficits and the influence of interventions or rehabilitation. 109 
To date, however, no model of gait has been developed for chronic mTBI, which limits the 110 
understanding of gait disturbance in this population.  Previous studies have shown that depending 111 
on the population being studied (e.g. older adults, Parkinson’s disease etc.) gait model domains 112 
may vary in terms of gait characteristics that load onto specific domains. For example, some gait 113 
characteristics (e.g. step and stance time variability) have been found to load onto multiple 114 
domains (e.g. Pace and Variability) in Parkinson’s disease [13] but not in older adults [5]. 115 
Therefore, a specific gait model that contains key outcomes with respect to chronic mTBI 116 
pathology is required to reduce data to allow comprehensive gait analysis and direct comparison 117 
to control groups in future studies in this population. 118 
This study builds on earlier work in different cohorts that include older adults and Parkinson’s 119 
disease [5, 7, 13-15, 17, 18] and uses PCA to derive independent gait domains in chronic mTBI. 120 
Additionally, this study validates the derived model in a separate group of age matched healthy 121 
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controls. Our aim was to determine a gait model in chronic mTBI to allow robust understanding of 122 
the underlying construct of gait in this population and to guide variable selection for future 123 
research (data reduction). 124 
2. Methods 125 
2.1. Participants 126 
Subjects who had an mTBI with self-reported balance instability >3 months after their initial injury 127 
were recruited as part of a larger study evaluating chronic mTBI. A total of 52 participants with 128 
chronic mTBI and 59 age matched healthy controls were included in this study. Full details of the 129 
mTBI classification, recruitment process and study can be found elsewhere [19]. Briefly, inclusion 130 
criteria consisted of (1) were >3 months post mTBI with persistent balance complaints for the 131 
mTBI group, or had no history of brain injury in the past year for the control group, (2) had no 132 
cognitive deficits as determined by the Short Blessed Test (score ≤8), and (3) were between the 133 
ages of 18 and 60 years. Exclusion criteria consisted of musculoskeletal injury in the previous 134 
year that could have seriously impacted gait or balance; current moderate or severe substance 135 
abuse; any peripheral vestibular or oculomotor pathology from before their reported mTBI; or 136 
refusal to abstain from medications that could impact their mobility for the duration of testing. 137 
Participants were asked to abstain from medications that could impact their mobility starting 24 138 
hours prior to their first testing date. Prohibited medications included sedatives, benzodiazepines, 139 
narcotics pain medications and alcohol. All recruitment procedures were approved by the Oregon 140 
Health & Science University (OHSU) and Veterans Affairs Portland Health Care System 141 
(VAPORHCS) joint institutional review board and participants provided written informed consent 142 
prior to commencing the study.  143 
2.2. Clinical Assessment 144 
Age, sex, height (m) and mass (kg) were recorded for all of the participants. Symptom severity 145 
was measured using the Neurobehavioral Symptoms Index (NSI) [20]. Days since injury was also 146 
recorded for the mTBI group.  147 
2.3. Gait Assessment 148 
Participants wore five inertial sensors (Opals, v.1, APDM, Inc., 128Hz) strapped to their feet, 149 
lumbar (L5), sternum and head while they walked at their comfortable speed for two minutes back 150 
and forth over a 13m distance along a firm surfaced hallway.  151 
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2.4. Gait Characteristics for Principle Component Analysis 152 
The rationale for inclusion of gait characteristics into our PCA was based upon the following;  153 
1) Metrics from MobilityLab: To facilitate replication in future studies and in line with previous 154 
research [17, 18], only gait metrics that were automatically provided by MobilityLab (v.2) were 155 
included. Therefore, step length and asymmetry metrics were not included and standard 156 
deviations (SD) were used rather than coefficient of variability. SDs have also been used in 157 
previous gait models, as they are suggested to be easier for non-technical audiences to 158 
interpret [21]. 159 
2) Metrics from Literature: Earlier work that has investigated discrete aspects of gait in healthy 160 
controls and people with mTBI [4] highlighted that gait speed, stride length, stride time and 161 
double support time were the only variables widely examined in previous mTBI gait studies. 162 
We also examined previous gait models to include a sufficient number and range of gait 163 
characteristics and ensure the model accurately represented the underlying construct (gait) 164 
[14, 22, 23], while avoiding duplication and redundancy [5, 7, 13-15]. In line with other models 165 
we used single and double support time, rather than stance and swing time to avoid 166 
redundancy, as these features have been used in previous mTBI literature [4]. Additionally, 167 
we examined methodological factors and reliability of inertial sensor gait metrics to ensure 168 
robust metrics were included [24, 25]. 169 
3) Metrics from Group Comparison: Due to the limited range of gait metrics that have 170 
previously been assessed in mTBI populations, we examined the effect size of a 171 
comprehensive range of gait metrics between our chronic mTBI and control subjects to inform 172 
clinically useful metrics to enter into our gait model (Table 1). We also included several novel 173 
gait metrics, derived from the inertial sensors, which have not been included in previous gait 174 
models, such as foot angles and turning characteristics. Mean gait characteristics that had a 175 
d>0.5 effect size (i.e. medium effect size or greater) were considered for entry into the gait 176 
model, along with relevant SDs. All metrics that were considered for model entry are detailed 177 
above or shown in Table 1. 178 
2.5. Data Analysis 179 
Inertial sensor data were processed through MobilityLab (v.2, APDM, Inc.) [26] which provided 180 
the 16 gait characteristics included in statistical analysis. Data were analyzed in SPSS (v. 24, 181 
IBM, USA), checked for normality with Kolomogrov-Smirnov tests along with box-plots, with 182 
parametric analysis used. Means and SD described demographic data, with independent t-tests 183 
used for continuous data comparisons and Pearson Chi-square test used for frequency data 184 
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comparisons. Statistical tests were two-tailed with a p<0.05 considered significant. Gait data were 185 
described in terms of Mean and SD, with Cohen’s effect sizes (d) used to examine the magnitude 186 
of differences between groups, and to inform gait variable entry into our PCA. Gait variability 187 
characteristics were log transformed to improve normality of distribution, in line with previous 188 
research [5].  189 
2.5.1. Principle Component Analysis 190 
Principle component analysis was used to identify independent gait domains for mTBI. A varimax 191 
rotation was applied to derive orthogonal factor scores with a minimum eigenvalue for extraction 192 
set to 1 [27]. Scree plots, component loadings, item loadings and cross-loadings were examined. 193 
In line with previous gait models developed with a similar sample size [15], items that met a 194 
minimum loading of 0.60 were considered relevant to each domain. To validate our mTBI gait 195 
model (i.e. examine model robustness), we replicated the PCA analysis in a group of age-196 
matched healthy controls.  197 
3. Results 198 
3.1. Participants 199 
Demographic and gait characteristics of the mTBI and control participants are provide in Table 1. 200 
The mTBI group were on average 551 days since injury, with a wide range from 283 to 1013 days 201 
since injury reported. The NSI score showed that the mTBI participants were symptomatic 202 
compared with normative values (e.g. 6-13 [20]), and significantly symptomatic compared with 203 
the controls (p<.001).  204 
There were several impaired gait characteristics in mTBI compared with controls (Table 1), 205 
although some variability (SD) features had small (<0.40) effect sizes between the groups. Toe 206 
off angle (d=0.07) and number of steps performed when turning (d=0.10) had marginal effect 207 
sizes for differences between the groups, which highlighted that they may not be useful for mTBI 208 
populations and that we may need more sensitive or validated measures of these features. 209 
Therefore, toe off angle and number of steps when turning were not entered into the further PCA 210 
analysis.  211 
3.2. Principle Component Analysis 212 
Thirteen gait characteristics were entered into the PCA yielding four domains (Variability, Rhythm, 213 
Pace and Turning) that accounted for 80.8% of variance for mTBI gait and 77.4% of the variance 214 
for control gait. These findings highlighted that the mTBI gait model was replicated in the healthy 215 
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controls, with consistent between-component loadings between the groups. Within both groups, 216 
Variability accounted for the largest amount of variance in gait, followed by Rhythm, Pace and 217 
Turning (Table 2). The majority of gait characteristics loaded onto one domain (>0.600) for both 218 
groups, however gait speed cross-loaded onto both Rhythm (0.623) and Pace (0.630) domains 219 
for controls with higher loading onto Pace (Table 2). Cross-loading may indicate that gait speed 220 
and timing features of gait are linked.  221 
4. Discussion 222 
This is the first study to determine a conceptual gait model in those with chronic mTBI, which we 223 
replicated within a group of age-matched healthy controls. Such conceptual models of gait are 224 
useful to provide a simple framework for selecting and reducing gait characteristics for further 225 
analysis, which is particularly required when using wearable sensors that provide a plethora of 226 
gait outcomes. We confirmed the presence of four independent gait domains in chronic mTBI and 227 
controls, which supports the idea that gait is not a singular construct but is made up of 228 
independent characteristics. Previous studies have suggested that independence is due to 229 
different neural mechanisms (i.e. specific brain regions, processes or substrates) underpinning 230 
the separate gait domains [5, 9, 13]. Additionally, we demonstrated that when our gait model was 231 
applied to both mTBI and healthy controls, the domains remained the same, with similar levels of 232 
explained variance (i.e. mTBI 80.8% vs controls 77.4%), which is in line with previously developed 233 
gait models [5, 13]. This is vital to aid in examination of specific gait impairments with chronic 234 
mTBI. 235 
4.1. Gait Model Development 236 
Our gait model for chronic mTBI contained a comprehensive range of gait variables while avoiding 237 
redundancy. The selection of gait characteristics for the developed model was based on several 238 
factors, such as; a number of robust gait features, avoiding duplication and including measures 239 
previously reported in mTBI studies. We also included novel measures of gait (e.g. foot angles 240 
and turning) in our model, as these were available due to the use of multiple wearable inertial 241 
sensors (one on each foot and one at the waist) [26]. Of note, other studies have not been able 242 
to include turning or foot angle variables due reporting gait assessment with instrumented 243 
walkways or single inertial sensors [5, 7, 13-15, 17]. Likewise, measures not automatically 244 
exported through MobilityLab were not included. The use of inertial sensors, therefore, resulted 245 
in subtle but important differences in our gait model compared to previous models [5, 7, 13, 14]. 246 
For example, similar to some previous gait models [7, 17], we did not include asymmetry within 247 
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our model as this feature was not automatically exported from MobilityLab. Nonetheless, 248 
asymmetry is not known to be a key feature of mTBI gait, unlike other pathological gait disorders 249 
(e.g. Parkinson’s disease or Stroke) [2, 13, 15], and may be interesting to examine in future 250 
studies. 251 
4.2. Gait Model Domains 252 
The gait domains identified in this study were similar to previous models in older adults [5, 7] and 253 
Parkinson’s disease [13, 15, 17], with variability, rhythm and pace being common amongst 254 
previous models. However, we found that explained variance in gait was slightly different between 255 
our model and previous models, as Variability accounted for the largest variance in the model, 256 
followed by Rhythm and Pace (Figure 1). Whereas other models have highlighted that pace or 257 
rhythm explained the most variance in older adults and pathological cohorts [5, 7, 13, 14, 17]. 258 
Differences in explained variance compared to previous studies may have occurred due to our 259 
model involving a different pathology (i.e. mTBI vs Parkinson’s disease [13, 15, 17]) and age 260 
range (i.e. previous studies were primarily in older adults [5, 7, 14]). Similarly, the current study 261 
involved a smaller cohort and used a lower number of gait characteristics in the model, i.e. 13 262 
compared to previous studies of 14 [2], 16 [5, 13], 18 [17] or 23 [14] characteristics. With the ability 263 
to derive turning metrics from the inertial sensors, we were able to derive a further independent 264 
domain of turning which emerged in both mTBI and control groups. In contrast, our recent 265 
Parkinson’s gait model showed that pace and turning gait characteristics loaded onto the same 266 
domain [18], which highlights the importance of distinguishing independent gait features in 267 
different neurological groups. Turning being an independent domain of gait is an important finding 268 
for an mTBI cohort, as turning has been shown to be sensitive to mTBI pathology in both acute 269 
[28, 29] and chronic stages [10]. Interestingly, turning explained the least amount of variance of 270 
gait in the groups (mTBI: 17.4%, control: 14.7%), which suggests that we may need more 271 
sensitive measures to reflect this complex aspect of gait.  272 
4.3. Gait Model Validation 273 
The validation of our developed mTBI gait model was performed by conducting the same PCA in 274 
a separate healthy control cohort. The model was well replicated in the separate group, which 275 
highlighted that our model is robust and stable across those with and without pathology. As a 276 
result, the model can be used in future studies to directly assess differences in comprehensive 277 
but independent gait domains, through analysis of domains scores or selection of gait 278 
characteristics from independent domains. Nevertheless, there were some unexpected findings. 279 
Specifically, we found that while gait speed primarily loaded onto the Pace domain in both groups, 280 
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it also loaded onto the Rhythm domain in healthy controls, which has not been previously reported 281 
[5, 7, 13, 14], but may be linked to the statistical relationship between speed and timing features 282 
of gait. Similarly, while the same gait features loaded onto the same domains in both chronic mTBI 283 
and control groups, the factor loading weights were different. These important differences 284 
highlighted that the gait model was more discrete (e.g. no cross-loading of gait characteristics 285 
onto different domains) within the pathological population than controls, similar to previous gait 286 
models [5, 7, 13, 14]. Differences in our findings compared to previous studies may relate to the 287 
different instruments used to derive gait metrics (i.e. inertial sensors compared to pressure sensor 288 
mats) and inclusion of different gait features (i.e. double and single support time instead of stance 289 
and swing time). Despite this, the domains found for our chronic mTBI cohort were replicated in 290 
a separate age-matched healthy control cohort, with very similar levels of explained variance.   291 
4.4. Future Directions 292 
In line with previous studies in other populations, our developed gait model simplifies gait 293 
measurement in mTBI, and demonstrates the independence of different gait characteristics [5, 7, 294 
13-15, 17, 18], such as variability, rhythm, pace and turning, but also addresses redundancy of 295 
features. Gait is often used as an outcome for studies that address the efficacy of treatments or 296 
therapeutics in mTBI [30, 31]. Studies of mTBI often adopt a detailed measurement of gait using 297 
sophisticated technologies and protocols that result in a wide range of metrics to select from [4, 298 
32-35], but despite this, gait is largely reported via a limited set of gait characteristics. Gait speed 299 
is primarily used across different neurological pathologies to report gait performance due to the 300 
ease and robustness of measurement [36], especially within clinical and laboratory settings for 301 
mTBI [37-39]. However, gait speed only reflect global gait performance and provides limited 302 
understanding of impairments seen in different pathologies [13], which is where a more 303 
comprehensive approach may add value. Similarly, gait characteristics, other than gait speed, 304 
may be useful for non-invasive discrimination between pathologies [40-42], with potential for gait 305 
to become a diagnostic tool for mTBI. Appropriate gait characteristics selection for mTBI studies 306 
would benefit from a more systematic and informed approach, which is where our developed gait 307 
model could add value to future studies. The primary benefit of a gait model for chronic mTBI is 308 
the reduced number of gait characteristics for further analysis, which avoids statistical issues with 309 
the number of variables examined (i.e. multiple comparisons) within cohorts of variable size. 310 
Researchers using the model can be confident that a wide range of characteristics are 311 
represented, while reducing analysis of redundant variables. Future studies can now use our 312 
developed gait model framework to select individual gait characteristics from independent gait 313 
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domains (e.g. double support time SD, double support time, stride length, turn duration) or 314 
combine gait characteristics within a domain using Z-scores for further analysis [8], or comparison 315 
to controls. 316 
4.5. Study Strengths and Limitations 317 
This study has several strengths and limitations that should be noted. The strengths of this study 318 
include the use of a commercially available inertial measurement units and MobilityLab software 319 
to record gait. This allowed simple, quick and easy collection of quantitative gait data that in the 320 
future could be performed in a variety of environments (e.g. clinics, research laboratories, home 321 
or community settings etc.). Additionally, inertial sensors allowed for the inclusion of novel and 322 
clinically relevant gait features (i.e. turning and foot angles). Another strength was the inclusion 323 
of a separate cohort of healthy controls to replicate the gait model that was derived for our mTBI 324 
cohort, which provided validation of the gait model. Only one previous study has examined a gait 325 
model within two separate cohorts in the same study [15], as other previous models have either 326 
only examined gait models within a single cohort [7, 14] or have replicated their model in a 327 
separate study [5, 13].  328 
The limitations of this study include the relatively small number of participants in each group, as 329 
the majority of previous gait model studies have included n>100 participants [5, 7, 13, 14]. 330 
Previous statistical research has suggested large numbers (e.g. n>100) are required to 331 
adequately perform PCA [43], however it is recognized that in observational studies this sample 332 
size is challenging [44, 45]. Therefore, others have recommended that the variable to sample size 333 
ratio can be as low as 2-6 subjects for each variable (e.g. 2:1 ratio) [46-49], which will achieve 334 
appropriate component loadings if the structure of the model (and underlying concept) is strong. 335 
Additionally, in line with a previous gait model with a similar size cohort (n=60) [15], to ensure 336 
robust domains we only considered variables that had component loadings >0.60 as opposed to 337 
larger cohort studies that have used >0.50 loadings to define variables loaded onto specific 338 
domains [5, 7, 13]. Another limitation was the lack of asymmetry gait variables included in the 339 
model. While measures of asymmetry may not be relevant to an mTBI population, they may 340 
provide a more comprehensive evaluation of gait, and could be included in future gait models. 341 
Finally, our mTBI cohort consisted of people who were still symptomatic >3months following their 342 
injury, and it should be noted that the developed gait model (i.e. domains loadings) may change 343 
in those who are asymptomatic or at different mTBI stages (i.e. acute, sub-acute etc.), which could 344 
be examined in future studies. 345 
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5. Conclusion 346 
This study presents a gait model to guide assessment and analysis of gait in chronic mTBI, which 347 
was replicated in a group of age-matched controls. We found that there were four domains of gait 348 
in chronic mTBI and controls, specifically Variability, Rhythm, Pace and Turning. The developed 349 
gait model provides a useful framework with which to assess the relationships between gait and 350 
the underlying mechanisms (or outcomes that represent these) of impairment. However, selection 351 
of gait characteristics in future analysis should be specific to pathology and the aims of 352 
investigation.  353 
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 Table 1 - Demographic and gait characteristics 534 
 Chronic mTBI (n=52)  Controls (n= 59) t df p 
Age (years) 39.56 (11.34) 36.96 (12.68) 1.14 110 .255 
Height (m) 171.08 (9.51) 171.60 (9.55) -0.29 110 .776 
Weight (kgs) 79.69 (19.51) 76.10 (19.39) 0.95 110 .347 
NSI score 36.51 (14.82) 3.92 (4.07) 16.23 110 <.001* 
Gender (m/f) 16 M / 37 F 25 M / 34 F 1.79† 1† .239† 
Days since injury˨ 551 (283, 1013) - - - - 
 Mean (SD) Mean (SD)   d 
Stride Length (m) 1.22 (0.12) 1.30 (0.11)   0.70 
Gait Speed (m/s) 1.09 (0.13) 1.21 (0.13)   0.93 
Foot Strike Angle (°) 23.61 (3.61) 26.11 (3.76)   0.68 
Toe off Angle (°) 39.35 (3.10) 39.56 (3.18)   0.07 
Single Support Time (%GCT) 39.52 (1.33) 40.41 (1.40)   0.66 
Double Support Time (%GCT) 10.49 (1.33) 9.61 (1.39)   0.65 
Stride Time (s) 1.12 (0.07) 1.08 (0.07)   0.58 
Foot Strike Angle SD (°) 1.66 (0.38) 1.56 (0.40)   0.26 
Toe off Angle SD (°) 1.25 (0.36) 1.12 (0.53)   0.29 
Stride Length SD (m) 0.04 (0.01) 0.04 (0.01)   0.00 
Single Support Time SD (%GCT) 0.69 (0.16) 0.63 (0.13)   0.42 
Double Support Time SD (%GCT) 1.07 (0.30) 0.96 (0.23)   0.42 
Stride Time SD (s) 0.02 (0.01) 0.02 (0.01)   0.45 
Turn Duration (s) 2.34 (0.44) 2.09 (0.37)   0.62 
Turn Step Number (n) 3.61 (0.67) 3.54 (0.72)   0.10 
Turn Velocity (°/s) 161.18 (33.68) 197.76 (43.55)   0.94 
[˨= Median and Inter-quartile range: 25th and 75th percentiles, †Chi-square, mTBI = mild traumatic brain injury, m = meters, s = 535 
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Table 2 – Principle Component Analysis of Gait Characteristics 542 
[Bold text = component loading >0.60, m = meters, s = seconds, %GCT = percentage of gait cycle time, n = number, ROM = range of movement] 543 
 Chronic mTBI (n=52)  Control (n=59) 
 Variability Rhythm Pace Turning  Variability Rhythm Pace Turning 
Double Support Time SD 0.813 -0.004 -0.418 -0.133  0.815 0.182 -0.247 0.185 
Stride Length SD 0.789 0.032 0.221 0.006  0.823 0.069 0.248 -0.212 
Foot Strike Angle SD 0.783 0.117 -0.127 0.229  0.726 -0.032 0.051 0.105 
Single Support Time SD 0.777 -0.033 -0.500 -0.146  0.845 0.167 -0.261 0.277 
Stride Time SD 0.722 0.173 -0.425 0.120  0.612 -0.201 -0.364 -0.097 
          
Double Support Time 0.070 0.962 -0.066 0.094  -0.195 -0.905 -0.063 -0.166 
Stride Time 0.044 0.602 0.110 0.561  0.167 -0.699 0.059 -0.283 
Single Support Time -0.072 -0.962 0.077 -0.093  0.197 0.907 0.064 0.165 
          
Stride Length -0.197 -0.186 0.910 -0.099  -0.128 0.285 0.846 0.062 
Gait Velocity -0.187 -0.482 0.695 -0.373  -0.194 0.623 0.630 0.227 
Foot Strike Angle -0.132 0.173 0.664 -0.168  -0.010 -0.311 0.739 0.165 
          
Turn Duration -0.031 0.095 -0.162 0.914  -0.112 -0.252 -0.098 -0.880 
Turn Velocity -0.085 -0.136 0.228 -0.898  0.087 0.298 0.219 0.864 
% Variance 
(80.8% total) 24.1 19.9 19.4 17.4 
% Variance 
(77.4% total) 24.1 22.8 15.8 14.7 
